D3 dopamine receptor-deficient mouse: Evidence for reduced anxiety

Physiology and Behavior

Volumn 63, Issue 1, 1997, Pages 137-141

  Steiner, Heinz ^a   Fuchs, Sara ^b   Accili, Domenico ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Anxiety; Anxiolytic; D3 dopamine receptors; Dopamine; Elevated plus maze; Knockout; Open field

Indexed keywords

DOPAMINE 3 RECEPTOR; DOPAMINE 2 RECEPTOR; DRD3 PROTEIN, MOUSE;

ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MALE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CHIMERA; EXPLORATORY BEHAVIOR; GENETICS; MOTOR ACTIVITY; MOUSE MUTANT; MUTAGENESIS; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANIMALS; ANXIETY; CHIMERA; EXPLORATORY BEHAVIOR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTAGENESIS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 0030608822     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(97)00430-7     Document Type: Article

References (36)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA. 93:1996;1945-1949.
2. Bouthenet M.-L., Souil E., Martres M.-P., Sokoloff P., Giros B., Schwartz J.-C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry Comparison with dopamine D2 receptor mRNA . Brain Res. 564:1991;203-219.
3. Costall B., Hendrie C. A., Kelly M. E., Naylor R. J. Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacology. 26:1987;195-200.
4. Crawley J. N. Unusual behavioral phenotypes of inbred mouse strains. Trends Neurosci. 19:1996;181-182.
5. Cruz A. P. M., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-176.
6. Daly S. A., Waddington J. L. Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists. Neuropharmacology. 32:1993;509-510.
7. Dawson G. R., Tricklebank M. D. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol. Sci. 16:1995;33-36.
8. Flint J., Corley R., DeFries J. C., Fulker D. W., Gray J. A., Miller S., Collins A. C. A simple genetic basis for a complex psychological trait in laboratory mice. Science. 269:1995;1432-1435.
9. Gerlai R. Gene-targeting studies of mammalian behavior Is it the mutation or the background genotype? Trends Neurosci. 19:1996;177-181.
10. Graeff F. G. Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals. Braz. J. Med. Biol. Res. 27:1994;811-829.
11. Gray J. A. The psychology of fear and stress. 1987;Cambridge University Press, Cambridge.
12. Grossen N. E., Kelley M. J. Species-specific behavior and acquisition of avoidance behavior in rats. J. Comp. Physiol. Psychol. 81:1972;307-310.
13. Hall C. S. Emotional behavior in the rat. III. The relationship between emotionality and ambulatory activity. J. Comp. Psychol. 22:1936;345-352.
14. 3 receptor mRNA and binding sites in human brain. Mol. Brain Res. 18:1993;187-192.
15. Large C. H., Stubbs C. M. The dopamine D3 receptor Chinese hamsters or Chinese whispers? Trends Pharmacol. Sci. 15:1994;46-47.
16. Lathe R. Mice, gene targeting and behaviour More than just genetic background . Trends Neurosci. 19:1996;183-186.
17. Lister R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
18. Moisan M.-P., Courvoisier H., Bihoreau M.-T., Gauguier D., Hendley E. D., Lathrop M., James M. R., Mormède P. A major quantitative trait locus influences hyperactivity in the WKHA rat. Nature Genet. 14:1996;471-473.
19. Moriizumi T., Leduc-Cross B., Wu J.-Y., Hattori T. Separate neuronal populations of the rat substantia nigra pars lateralis with distinct projection sites and transmitter phenotypes. Neuroscience. 43:1992;711-720.
20. Pellow S., Chopin P., File S. E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Meth. 14:1985;149-167.
21. Pich E. M., Samanin R. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats Possible role of dopamine . Psychopharmacology. 89:1986;125-130.
22. Puglisi-Allegra S., Cabib S. Pharmacological evidence for a role of D2 dopamine receptors in the defensive behavior of the mouse. Behav. Neural Biol. 50:1988;98-111.
23. Rodgers R. J., Cole J. C., Aboualfa K., Stephenson L. H. Ethopharmacological analysis of the effects of putative "anxiogenic" agents in the mouse elevated plus-maze. Pharmacol. Biochem. Behav. 52:1995;805-813.
24. Rodgers R. J., Johnson N. J. T., Champion A. J., Mills S. Modulation of plus-maze behaviour in mice by the preferential D3-receptor agonist 7-OH-DPAT. Pharmacol. Biochem. Behav. 54:1996;79-84.
25. Rodgers R. J., Nikulina E. M., Cole J. C. Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;985-995.
26. Seeman P., Van Tol H. H. M. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:1994;264-270.
27. Sibley D. R., Monsma F. J. Jr. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:1992;61-69.
28. Simpson E. M., Linder C. C., Sargent E. E., Davisson M. T., Mobraaten L. E., Sharp J.J. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nature Genet. 16:1997;19-27.
29. 3) as a target for neuroleptics. Nature (London). 347:1990;146-151.
30. Standish-Barry H. M., Bouras N., Bridges P. K., Watson J. P. A randomized double blind group comparative study of sulpiride and amitriptyline in affective disorder. Psychopharmacology. 81:1983;258-260.
31. Svensson K., Carlsson A., Huff R. M., Kling-Petersen T., Waters N. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur. J. Pharmacol. 263:1994;235-243.
32. Svensson K., Carlsson A., Waters N. Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J. Neural Transm. 95:1994;71-74.
33. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 31:1989;959-962.
34. Walsh R. N., Cummins R. A. The open-field test A critical review . Psychol. Bull. 83:1976;482-504.
35. Waters N., Svensson K., Haadsma-Svensson S.R., Smith M. W., Carlsson A. The dopamine D3-receptor A postsynaptic receptor inhibitory on rat locomotor activity . J. Neural Transm. 94:1993;11-19.
36. Whimbey A. E., Denenberg V. H. Two independent behavioral dimensions in open-field performance. J. Comp. Physiol. Psychol. 63:1967;500-504.